Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure

    ... Survival after azacitidine (AZA) failure in higher-risk myelodysplastic syndromes (MDS) ...

    Research Article last updated 01/20/2015 - 1:14pm.

  2. A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial.

    ... The phase III AZA-001 study established that azacitidine significantly improves overall survival compared with ... disease progression). Achieving an Overall Response with azacitidine reduced risk of death by 95% compared with achieving an Overall ...

    Research Article last updated 05/14/2013 - 2:51pm.

  3. Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial

    ... syndromes with excess blasts after failure of azacitidine or decitabine treatment. METHODS: We did this ...

    Research Article last updated 06/07/2016 - 11:10am.

  4. Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes.

    ... Outcome of patients with myelodysplastic syndrome after azacitidine failure is poor. In this population, we combined cytarabine ...

    Research Article last updated 09/03/2013 - 12:32pm.

  5. Counselling and adverse event management for patients with myelodysplastic syndromes undergoing azacitidine therapy: a practice standard for Canadian nurses

    ... von Riedemann S, Kurtin S; Canadian Nurses Working Group on Azacitidine in MDS Original Publication Date:  ...

    Research Article last updated 03/05/2013 - 9:33am.

  6. Shelf-life Extension of Azacitidine: Waste and Cost Reduction in the Treatment of Myelodysplastic Syndromes

    ...

    Research Article last updated 06/19/2014 - 1:26pm.

  7. Real-Life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile

    ...

    Research Article last updated 02/04/2014 - 1:52pm.

  8. Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study

    ...

    Research Article last updated 02/04/2013 - 2:29pm.

  9. 5'-Azacitidine in myelodysplastic syndromes with inversion of chromosome 3.

    ...

    Research Article last updated 10/11/2011 - 5:58pm.

  10. CASCADE (SGN33A-005)

    ... talirine (SGN-CD33A; 33A) combined with either azacitidine or decitabine extends overall survival longer than placebo combined with either azacitidine or decitabine. Status:  ...

    Clinical Trial last updated 06/19/2017 - 2:43pm.